Strong antimicrobial activity of collinin and isocollinin against periodontal and superinfectant pathogens in vitro.


Journal

Anaerobe
ISSN: 1095-8274
Titre abrégé: Anaerobe
Pays: England
ID NLM: 9505216

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 25 11 2019
revised: 16 01 2020
accepted: 20 01 2020
pubmed: 3 2 2020
medline: 8 1 2021
entrez: 3 2 2020
Statut: ppublish

Résumé

Periodontitis pathogenesis involves activation of host immune responses triggered by microbial dysbiosis. Therefore, controlling periodontal pathogens in-vivo is a main goal of periodontal therapy. New antimicrobials might help to control periodontal infection and improve treatment outcomes at "the dark times" of increasing antibiotic resistance. Here, we determined the biological activity of collinin and isocollinin against 8 bacterial strains. Antimicrobial activity of collinin and isocollinin, chlorhexidine digluconate (CHX) and sodium hypochlorite (NaClO) was evaluated against clinically relevant periodontal bacteria, like Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Fusobacterium nucleatum, Prevotella intermedia, Dialister pneumosintes strains and superinfectants like Escherichia coli, Staphylococcusaureus, and Pseudomonasaeruginosa strains. A broth microdilution test was carried out to determine the minimum inhibitory concentration of collinin and isocollinin against those strains, and bacterial viability was determined by resazurin assay at diverse concentration and exposure times. P. gingivalis was the most susceptible strain to collinin and isocollinin (MIC 2.1 μg/mL and 4.2 μg/mL respectively). Other periodontal pathogens showed MICs <17 μg/mL for collinin and MICs between 20 and 42 μg/mL for isocollinin, whereas CHX and NaClO showed MICs of 62 and 326 μg/mL, respectively. Collinin and isocollinin also exhibited antimicrobial activity against superinfectant bacteria (MIC < 21 and < 42 μg/mL, respectively). Overall, collinin and isocollinin showed a remarkable antibacterial activity against relevant periodontal and superinfective bacteria, especially against P. gingivalis (MIC 2.1 μg/mL and 4.2 μg/mL respectively) and the highly virulent P. aeruginosa (MIC 5.2 and 20.8 μg/mL, respectively).

Identifiants

pubmed: 32007684
pii: S1075-9964(20)30019-6
doi: 10.1016/j.anaerobe.2020.102163
pii:
doi:

Substances chimiques

Coumarins 0
collinin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102163

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no competing financial interest.

Auteurs

Camilo Pardo-Castaño (C)

Applied Thermodynamic Research Group, School of Chemical Engineering, Universidad del Valle, 760032, Cali, Colombia.

Daniel Vásquez (D)

Periodontal Medicine Research Group, School of Dentistry, Universidad del Valle, 760043, Cali, Colombia.

Gustavo Bolaños (G)

Applied Thermodynamic Research Group, School of Chemical Engineering, Universidad del Valle, 760032, Cali, Colombia.

Adolfo Contreras (A)

Periodontal Medicine Research Group, School of Dentistry, Universidad del Valle, 760043, Cali, Colombia. Electronic address: adolfo.contreras@correounivalle.edu.co.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH